Soleus Capital Management’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-67,121
Closed -$5.5M 113
2024
Q1
$5.5M Sell
67,121
-369,079
-85% -$30.3M 0.41% 63
2023
Q4
$8.12M Buy
436,200
+314,000
+257% +$5.84M 0.9% 36
2023
Q3
$1.35M Sell
122,200
-214,500
-64% -$2.37M 0.12% 74
2023
Q2
$5.46M Sell
336,700
-123,300
-27% -$2M 0.61% 46
2023
Q1
$7.66M Buy
+460,000
New +$7.66M 0.79% 35